A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

NCT05597020 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder
Nocturia

Interventions

DRUG: Daridorexant
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.